Overexpression of SIRT6 Suppresses TNFα‐induced Muscle Cell Atrophy via NFκB Inhibition

Authors:

Abstract
Chronic inflammation is a primary cause of muscle atrophy partly due to nuclear factor (NF)κB‐mediated upregulation of pro‐inflammatory cytokines such as TNFα, IL‐6, and IL‐1β. SIRT6, a NAD + dependent histone deacetylase has been shown to suppress inflammatory responses by inhibiting NFκB signaling in several mammalian cells, but its role in muscle atrophy has never been studied. PURPOSE: The aim of this study was to investigate whether SIRT6 overexpression (OE) can prevent TNFα‐induced proteolysis and atrophy in skeletal muscle cells. METHODS: C2C12 cells were cultured in DMEM supplemented with 10% FBS, 100 U/ml pen:strep in 37°C with 5% CO 2 incubator. Transient transfections were performed with 2 ng of GFP or Flag‐SIRT6 DNA transfected with PEI transfection reagent in 70% confluency cells. After 24 h, various doses of TNFα were added and the cells were incubated for various times. RESULTS: After 48 h TNFα‐treated cells decreased SIRT6 level in a dose‐dependent manner, whereas this effect was abolished in SIRT6 OE cells. GFP+TNFα decreased IκBα content and increased nuclear p65 level indicating NFκB activation; however, SIRT6+TNFα cells showed minimal effect compared to GFP+TNFα. P65 DNA binding was increased by 6.7, 3.5, 4.2, 3.9‐fold with GFP+TNFα at 10min, 1h, 2h, and 6h, respectively ( P P P P <0.05), whereas this effect was abolished in SIRT6 OE cells. TNFα treatment increased reactive oxygen species (ROS) production in a dose‐dependent manner (P<0.05), but ROS showed no change with SIRT6 OE. E3 ubiquitin ligase Atrogin‐1 level increased in response to TNFα in GFP but not in SIRT6 OE cells. TNFα treatment increased MuRF‐1 levels in GFP+TNFα; however, the effect tends to be lower in SIRT6 OE cells. The cell viability was decreased in TNFα treatment (P<0.01), but not in SIRT6 OE cells. CONCLUSION: Overexpression of SIRT6 reduced pro‐inflammatory cytokine transactivation and ROS production, and improved viabilities possibly due to inhibition of TNFα‐induced NFκB activation in C2C12 cells.